London-based healthcare specialist Double Helix Development group has relocated its Scarsdale, New York consulting operations to midtown Manhattan, in anticipation of growth from the practice.
Double Helix Consulting US comprises a multidisciplinary team of healthcare industry pricing, reimbursement and market access consultants, who provide commercialization services to firms in the pharma, biotech and medical device industries.
Services span the product lifecycle and include areas such as product value message development and testing, commercial assessments, payer and provider insight evaluation and influence planning.
Group CEO Dr Wayne Phillips explains: ‘Double Helix Consulting’s US operations are now situated in the heart of the northeastern biopharma belt running from greater Boston to Washington, close to its core customer base. We’re confident our New York office is an attractive and exciting location for recruiting talented individuals who represent our greatest asset.’
In January, Ann Stuchiner joined
the team as Vice President, having previously led product planning initiatives in many therapeutic areas such as oncology, neurosciences, infectious disease, cardiometabolics, gastroenterology and pain.
The group’s other offices are in London; and Fort Washington, Pennsylvania.
Web site: www.doublehelixdevelopment.com